The list of valsartan products that are NOT recalled has been updated to: provide corrected information for Diovan products; add an additional Mylan-Valsartan product; and to add Entresto products ...

A multi-district Valsartan lawsuit is underway to get compensation for people who used contaminated Valsartan. Here is what you need to know about it.

Dr. Reddy's Valsartan Tablets, USP are available in 40 mg in bottle count size of 30, and 80 mg, 160 mg and 320 mg tablets in bottle count sizes of 90.

Aliskiren and valsartan previously were approved as stand-alone products (Tekturna and Diovan, Novartis) and in combination with hydrochlorothiazide (Tekturna HCT and Diovan HCT, Novartis) for the ...

Lupin Pharmaceuticals Inc, the US-based subsidiary of the company, has launched its Valsartan tablets in strengths of 40 mg, 80 mg, 160 mg and 320 mg in the US market after getting nod from the US ...

Dr. Reddy’s Valsartan Tablets, USP are available in 40 mg in bottle count size of 30, and 80 mg, 160 mg and 320 mg tablets in bottle count sizes of 90.

Diovan 80 mg and 160 mg are both approved starting doses for hypertension. Diovan 160 mg is recommended for patients requiring greater blood pressure reductions (if they are not volume-depleted).

Dr. Reddy’s Valsartan Tablets are available in 40 mg in bottle count size of 30, and 80 mg, 160 mg, and 320 mg tablets in bottle count sizes of 90. Comments Published on December 9, 2021 ...

OTTAWA, Aug. 18, 2018 /CNW/ - Health Canada is advising Canadians that, as a precautionary measure, Teva Canada is expanding its voluntary recall to include eight additional lots of valsartan ...

The Valsartan tablets, USP are available in 40 mg in bottle count size of 30, and 80 mg, 160 mg and 320 mg tablets in bottle count sizes of 90, Dr. Reddy’s said in a release.

Dr. Reddy’s Valsartan Tablets, USP are available in 40 mg in bottle count size of 30, and 80 mg, 160 mg and 320 mg tablets in bottle count sizes of 90.

The Diovan® brand and generic market had U.S. sales of approximately $150 million MAT for the most recent twelve months ending in October 2021 according to IQVIA Health*. Dr. Reddy’s Valsartan Tablets ...